| Typicality: | 0.621 |
| Saliency: | 0.729 |
| often | 64 | temporal |
| with other drugs | 48 | other |
| with capecitabine | 40 | other |
| drug → be used in → combination | 414 |
| drug → be → combined | 87 |
| drug → be taken in → combination | 77 |
| drug → be given in → combination | 56 |
| drug → be prescribed in → combination | 24 |
| drug → be administered in → combination | 19 |
| drug → be → combination | 15 |
| drug → be to be used in → combination | 8 |
| drug → be found in → combination | 4 |
| drug → be included in → combination | 3 |
| drug → be used in → combination regimens | 3 |
| drug → be taken → combination | 3 |
| drug → be in → combination | 3 |
| negative | neutral | positive |
| 0.273 | 0.563 | 0.163 |
| Raw frequency | 716 |
| Normalized frequency | 0.729 |
| Modifier score | 0.684 |
| Perplexity | 128.058 |